title: Effects of acute in vivo cisplatin and selenium treatment on hematological and oxidative stress parameters in red blood cells of rats.
abstract: Although cisplatin (cisPt) is one of the most often used cytotoxic drugs in the treatment of cancer, its clinical application is associated with nephrotoxicity and a cumulative anemia. In this study, we evaluated posible protective effects of selenium (Se) on hematological and oxidative stress parameters in rats, acutely treated with cisPt. Four groups of Wistar albino rats included control rats, cisPt-treated (7.5 mg/kg of body weight of cisPt, i.p.), Se-treated (6 mg/kg of body weight of Na(2)SeO(4), i.p.), and Se and cisPt co-treated rats. The rats were killed 72 h after treatment; hematological and oxidative stress parameters were followed in red blood cells. The results showed depletion in platelet number induced by high acute doses of cisPt and strong utilization of reduced glutathione, resulting in elevation of GSSG/2 GSH ratio. Se treatment was followed by stimulated erythropoiesis, increased lipid peroxidation, and GSH depletion. Se and cisPt co-treatment were followed by stimulated erythropoiesis and significant recovery of reduced glutathione status when compared with cisPt-treated rats. In conclusion, acute doses of Se and cisPt primarily act as pro-oxidants. CisPt influenced antioxidative properties of exogenous Se and their synergistic effects may partially participate in protection against cisPt-induced toxicity.
authors.affiliation: Faculty of Science, Department for Biology and Ecology, University of Kragujevac, Radoja Domanovića 12, 34000 Kragujevac, P.O. Box 60, Serbia. smarkovic@kg.ac.rs
authors.forename: Snežana D
authors.initials: SD
authors.lastname: Marković
authors.forename: Dragana S
authors.initials: DS
authors.lastname: Djačić
authors.forename: Danijela M
authors.initials: DM
authors.lastname: Cvetković
authors.forename: Ana D
authors.initials: AD
authors.lastname: Obradović
authors.forename: Jovana B
authors.initials: JB
authors.lastname: Žižić
authors.forename: Branka I
authors.initials: BI
authors.lastname: Ognjanović
authors.forename: Andraš Š
authors.initials: AŠ
authors.lastname: Štajn
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects; D002945:Cisplatin / Q000009:adverse effects*; D004912:Erythrocytes / Q000187:drug effects* / Q000378:metabolism*; D008297:Male; D018384:Oxidative Stress / Q000187:drug effects*; D051381:Rats; D017208:Rats, Wistar; D017382:Reactive Oxygen Species / Q000378:metabolism; D012643:Selenium / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D017382:Reactive Oxygen Species; D012643:Selenium; D002945:Cisplatin